» Authors » Igor Bednarski

Igor Bednarski

Explore the profile of Igor Bednarski including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 58
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Gajewski B, Karlinska I, Domowicz M, Bednarski I, Swiderek-Matysiak M, Stasiolek M
Biomolecules . 2025 Jan; 15(1). PMID: 39858462
Despite significant efforts, there is still an existing need to identify diagnostic tools that would enable fast and reliable detection of the progressive stage of multiple sclerosis (MS) and help...
2.
Lesiak A, Wodz K, Ceryn J, Sobolewska-Sztychny D, Bednarski I, Piekarski J, et al.
Front Med (Lausanne) . 2025 Jan; 11():1483208. PMID: 39839625
Introduction: Inflammasomes NLRP1 (NLR family pyrin domain containing 1) and NLRP3 are pivotal regulators of the innate immune response, activated by a spectrum of endogenous and exogenous stressors, including ultraviolet...
3.
Mazan P, Lesiak A, Skibinska M, Rynkowska-Kidawa M, Bednarski I, Sobolewska-Sztychny D, et al.
Postepy Dermatol Alergol . 2024 Nov; 41(5):463-472. PMID: 39606603
Introduction: Chronic pruritus is one of the most common symptoms in geriatric patients. Pathogenesis of pruritus is multifactorial. Aim: To evaluate the prevalence and characteristics of pruritus in geriatric patients...
4.
Mazan P, Lesiak A, Bednarski I, Sobolewska-Sztychny D, Noweta M, Narbutt J
Medicina (Kaunas) . 2024 Oct; 60(10). PMID: 39459488
: Bullous pemphigoid (BP) is the most common autoimmune blistering disease affecting mainly elderly patients. Still, little is known about the pathogenesis of pruritus in BP or the factors that...
5.
Waszczykowski M, Fabis-Strobin A, Bednarski I, Narbutt J, Fabis J
Arch Med Sci . 2022 Mar; 18(2):448-458. PMID: 35316898
Introduction: Osteoarthritis (OA) is the most common degenerative joint disease, and its aetiology is not entirely known. The aim of the study was to evaluate the involvement of interleukin-18 (IL-18)...
6.
Galica K, Lesiak A, Ciazynska M, Noweta M, Bednarski I, Narbutt J
Postepy Dermatol Alergol . 2022 Feb; 38(6):973-978. PMID: 35126003
Introduction: Clinical experience indicates that secukinumab has significant efficacy in the treatment of moderate-to-severe psoriasis and psoriatic arthritis, demonstrating a rapid onset of action, sustained response, a favourable safety profile,...
7.
Olejniczak-Staruch I, Narbutt J, Ceryn J, Skibinska M, Bednarski I, Wozniacka A, et al.
Sci Rep . 2021 Apr; 11(1):9289. PMID: 33927259
Studies have shown that the levels of pro-inflammatory adipokines in patients with psoriasis are higher than in general population. The aim of the study was to investigate the influence of...
8.
Waszczykowski M, Bednarski I, Narbutt J, Waszczykowska E, Lesiak A, Fabis J
Postepy Dermatol Alergol . 2021 Feb; 37(6):1001-1008. PMID: 33603622
Introduction: Psoriatic arthritis (PsA) is a chronic, seronegative spondyloarthropathy characterised by joint inflammation and psoriatic skin changes. Recent data indicate that interleukin-18 (IL-18) and interleukin-20 (IL-20) may be involved in...
9.
Waszczykowski M, Bednarski I, Lesiak A, Waszczykowska E, Narbutt J, Fabis J
Postepy Dermatol Alergol . 2021 Feb; 37(6):995-1000. PMID: 33603621
Introduction: Effective treatment in psoriatic arthritis (PsA) patients can protect them from severe musculoskeletal complications. For appropriate monitoring of anti-tumour necrosis factor α (anti-TNF-α) treatment in PsA, specific biomarkers are...
10.
Waszczykowski M, Fabis-Strobin A, Bednarski I, Lesiak A, Narbutt J, Fabis J
Diagnostics (Basel) . 2021 Jan; 11(1). PMID: 33396347
The aim of this study was to find characteristic biomarkers in the serum of patients with osteoarthritis (OA) and psoriatic arthritis (PsA) responsible for inflammation and destruction of joint cartilage,...